[go: up one dir, main page]

CA2260332A1 - Culture et transduction non virales et efficaces d'erythrocytes - Google Patents

Culture et transduction non virales et efficaces d'erythrocytes Download PDF

Info

Publication number
CA2260332A1
CA2260332A1 CA002260332A CA2260332A CA2260332A1 CA 2260332 A1 CA2260332 A1 CA 2260332A1 CA 002260332 A CA002260332 A CA 002260332A CA 2260332 A CA2260332 A CA 2260332A CA 2260332 A1 CA2260332 A1 CA 2260332A1
Authority
CA
Canada
Prior art keywords
cells
erythroid
epor
gene
electroporation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002260332A
Other languages
English (en)
Inventor
Kathryn Matthews
Susan Mueller
David Bell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Hemosol Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hemosol Inc filed Critical Hemosol Inc
Priority to CA002260332A priority Critical patent/CA2260332A1/fr
Priority to CA002331776A priority patent/CA2331776A1/fr
Priority to EP99928951A priority patent/EP1104455A2/fr
Priority to AU45956/99A priority patent/AU760883B2/en
Priority to PCT/CA1999/000606 priority patent/WO1999067360A2/fr
Priority to US09/339,838 priority patent/US6361998B1/en
Publication of CA2260332A1 publication Critical patent/CA2260332A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0641—Erythrocytes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C12N2500/24—Iron; Fe chelators; Transferrin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C12N2500/24—Iron; Fe chelators; Transferrin
    • C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/36—Lipids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/14—Erythropoietin [EPO]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA002260332A 1998-06-25 1999-01-25 Culture et transduction non virales et efficaces d'erythrocytes Abandoned CA2260332A1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
CA002260332A CA2260332A1 (fr) 1999-01-25 1999-01-25 Culture et transduction non virales et efficaces d'erythrocytes
CA002331776A CA2331776A1 (fr) 1998-06-25 1999-06-25 Culture efficace de cellules souches permettant la production d'hemoglobine
EP99928951A EP1104455A2 (fr) 1998-06-25 1999-06-25 Culture efficace de cellules souches permettant la production d'hemoglobine
AU45956/99A AU760883B2 (en) 1998-06-25 1999-06-25 The efficient culture of stem cells for the production of hemoglobin
PCT/CA1999/000606 WO1999067360A2 (fr) 1998-06-25 1999-06-25 Culture efficace de cellules souches permettant la production d'hemoglobine
US09/339,838 US6361998B1 (en) 1998-06-25 1999-06-25 Efficient culture of stem cells for the production of hemoglobin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002260332A CA2260332A1 (fr) 1999-01-25 1999-01-25 Culture et transduction non virales et efficaces d'erythrocytes

Publications (1)

Publication Number Publication Date
CA2260332A1 true CA2260332A1 (fr) 2000-07-25

Family

ID=29555033

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002260332A Abandoned CA2260332A1 (fr) 1998-06-25 1999-01-25 Culture et transduction non virales et efficaces d'erythrocytes

Country Status (1)

Country Link
CA (1) CA2260332A1 (fr)

Similar Documents

Publication Publication Date Title
US6361998B1 (en) Efficient culture of stem cells for the production of hemoglobin
Migliaccio et al. GATA-1 as a regulator of mast cell differentiation revealed by the phenotype of the GATA-1low mouse mutant
US6225119B1 (en) Production of megakaryocytes by the use of human mesenchymal stem cells
JP5717311B2 (ja) 霊長類の胚幹細胞の無血清培養
US20180092945A1 (en) Multipotent stem cells and uses thereof
TWI239352B (en) Gene transfer method with the use of serum-free medium
US20170313983A1 (en) Multipotent stem cells and uses thereof
CN108350429A (zh) 用于将多能干细胞定向分化为免疫细胞的方法
JPH09502359A (ja) 造血前駆細胞の調製及び培養方法
JP2008501333A (ja) 赤血球細胞の生産方法
JP2010525836A (ja) ヒト造血幹細胞のｅｘｖｉｖｏ増殖
KR20140011912A (ko) 인간 적혈구 전구세포주 및 인간 탈핵 적혈구의 제조방법
US20070243608A1 (en) Platelet bioreactor
KR20180015613A (ko) 거핵구를 포함하는 배양물의 제조 방법 및 이를 사용한 혈소판의 제조 방법
CA2260332A1 (fr) Culture et transduction non virales et efficaces d'erythrocytes
CN107630039A (zh) 缺氧条件下诱导hpv16 e6/e7基因表达的慢病毒表达载体
Wong et al. Establishment of an erythroid cell line from primary CD36+ erythroid progenitor cells
CA2241576A1 (fr) Transduction efficace non virale et culture de cellules erythrocytes
JP7630132B2 (ja) 巨核球前駆細胞および巨核球細胞の製造方法並びに得られた巨核球前駆細胞および巨核球細胞
US20240254445A1 (en) Composition containing feeder cell for proliferating natural killer cell
AU760883B2 (en) The efficient culture of stem cells for the production of hemoglobin
AU2019376495B2 (en) Method for producing erythroid cells
CA2331776A1 (fr) Culture efficace de cellules souches permettant la production d'hemoglobine
JP3962459B2 (ja) 造血幹細胞の分化・増殖調節方法
KR20240005600A (ko) 유전자 과발현 조합을 이용한 적혈구 분화능이 우수한불멸화 적혈구전구세포주 확립, 이의 제조방법 및 용도

Legal Events

Date Code Title Description
FZDE Dead